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Abstract
Neurotoxicity in all prion disorders is believed to result from the accumulation of PrP-scrapie (PrP
Sc), a b-sheet rich isoform
of a normal cell-surface glycoprotein, the prion protein (PrP
C). Limited reports suggest imbalance of brain iron homeostasis
as a significant associated cause of neurotoxicity in prion-infected cell and mouse models. However, systematic studies on
the generality of this phenomenon and the underlying mechanism(s) leading to iron dyshomeostasis in diseased brains are
lacking. In this report, we demonstrate that prion disease–affected human, hamster, and mouse brains show increased total
and redox-active Fe (II) iron, and a paradoxical increase in major iron uptake proteins transferrin (Tf) and transferrin receptor
(TfR) at the end stage of disease. Furthermore, examination of scrapie-inoculated hamster brains at different timepoints
following infection shows increased levels of Tf with time, suggesting increasing iron deficiency with disease progression.
Sporadic Creutzfeldt-Jakob disease (sCJD)–affected human brains show a similar increase in total iron and a direct
correlation between PrP and Tf levels, implicating PrP
Sc as the underlying cause of iron deficiency. Increased binding of Tf to
the cerebellar Purkinje cell neurons of sCJD brains further indicates upregulation of TfR and a phenotype of neuronal iron
deficiency in diseased brains despite increased iron levels. The likely cause of this phenotype is sequestration of iron in brain
ferritin that becomes detergent-insoluble in PrP
Sc-infected cell lines and sCJD brain homogenates. These results suggest
that sequestration of iron in PrP
Sc–ferritin complexes induces a state of iron bio-insufficiency in prion disease–affected
brains, resulting in increased uptake and a state of iron dyshomeostasis. An additional unexpected observation is the
resistance of Tf to digestion by proteinase-K, providing a reliable marker for iron levels in postmortem human brains. These
data implicate redox-iron in prion disease–associated neurotoxicity, a novel observation with significant implications for
prion disease pathogenesis.
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Introduction
Imbalance of brain iron homeostasis is considered an important
contributing factor of neurotoxicity in several neurodegenerative
disorders including Parkinson’s disease, Alzheimer’s disease, and
Huntington’s disease [1–4]. Recent evidence suggests a similar
alteration of iron homeostasis in prion disorders, a group of
neurodegenerative conditions affecting humans and animals [5–
10]. Since prion disorders are believed to result from a change in
the conformation of cellular prion protein (PrP
C) from an a-helical
to a b-sheet rich PrP-scrapie form (PrP
Sc), disturbance of brain
iron homeostasis is an unexpected outcome [11,12]. Direct
demonstration of increased total iron including Fe
2+ and Fe
3+
ions in the cerebral cortex, striatum, and brain stem of scrapie-
infected mice, and an increase in markers of oxidative stress such
as free malondialdehyde in diseased brains supports a role for
redox-iron in prion disease pathogenesis, though the generality of
this phenomenon and the underlying cause remain unidentified
[5,6,10,13].
Bearing in mind the pathophysiology of prion disorders, it is
difficulttoexplaindisruptionofironmetabolismbytheconversionof
PrP
CtoPrP
Sc,theprincipaleventinallpriondisorders.Undernormal
conditions, cellular iron homeostasis is maintained by a set of iron
regulatory proteins that respond to intracellular iron levels by
regulating their expression. In iron deficient conditions, iron uptake
proteins transferrin (Tf) and transferrin receptor (TfR) are up
regulated, and the iron storage protein ferritin is down regulated.
The net result is an increasein the bio-available labile iron pool. The
opposite scenario takes effect when iron is in excess [14]. A tight
regulation of cellular iron is important since iron is not only an
essential component of enzymes and proteins required for optimal
neuronalgrowthandfunction,butisalsotoxicduetoitsabilitytoexist
intwooxidationstates,ferric(Fe
3+)andferrous(Fe
2+)[14–16].Under
conditions where ferritin is unable to detoxify iron, Fe
2+ iron can
participate in one-electron transfer reactions such as Fenton or
Haber-Weiss’ reactions, resulting in cell death. Thus, alteration of
brainironhomeostasisindiseasedbrainsislikelytoinducesignificant
neurotoxicity, an observation that has received little attention [16].
PLoS Pathogens | www.plospathogens.org 1 March 2009 | Volume 5 | Issue 3 | e1000336Although the origin of iron imbalance in diseased brains is
unclear, in vitro studies conducted previously provide some clues to
the underlying mechanism(s). It is likely that the affinity of PrP
C
for iron and hemin and the influence of this interaction on its
conformational change to PrP
Sc renders iron inaccessible from
PrP
Sc aggregates [17,18]. This would increase total cellular iron
while decreasing the bio-available iron pool, inducing a state of
cellular iron deficiency in the presence of excess iron. Alternately,
since PrP is involved in cellular iron uptake and transport, a
disruption of this function by aggregation of PrP to the PrP
Sc form
may alter cellular iron homeostasis, creating a state of iron
imbalance [19]. Though plausible, this phenomenon has not been
evaluated in prion disease affected brains.
To fill this gap, we examined a large sample size of sporadic
Creutzfeldt-Jakob disease (sCJD) affected human brains, scrapie
infected mouse brains inoculated with the 139A strain [20], and
hamster adapted Transmissible Mink Encephalopathy (TME) or
263K scrapie inoculated hamster brains to investigate the presence
of iron imbalance during disease progression and at end-stage of
disease [21]. In addition to measuring brain iron levels, particular
attention was directed to Tf, the iron uptake protein that responds
to minor changes in cellular iron levels, is unaltered by disease
associated astrogliosis [2,14–16], and resists harsh protease
digestion (see below), making it possible to assess iron homeostasis
in post-mortem human brains. Snap frozen mouse and hamster
brains served as additional controls to rule out any effects of post-
mortem interval in the human tissue. In addition, cell models that
replicate prions in vitro were used to understand the underlying
cause of altered iron homeostasis due to prion infection [22,23].
We report that diseased human, hamster, and mouse brains show
signs of iron imbalance, confirming the generality of this
abnormality regardless of the prion strain or the affected species.
The alteration of brain iron status appears early in the disease
process, concomitant with the appearance of PrP
Sc, and is not an
outcome of end-stage disease. Furthermore, we demonstrate the
sequestration of iron in detergent insoluble PrP
Sc-ferritin com-
plexes in PrP
Sc infected cell models and in sCJD brain
homogenates, explaining the cause of iron imbalance in prion
disease affected brains.
Results
Prion disease–infected hamster brains show evidence of
brain iron imbalance
To evaluate if prion infection induces imbalance in brain iron
homeostasis, brain tissue from control (NH) and end-stage diseased
hamsters inoculated with the hyper strain (HY) of hamster adapted
TME (Ha
HY) [17] was assessed for PrP
Sc levels, total iron, redox-
active ferrous iron, and levels of major iron management proteins
Tf and ferritin. Accordingly, NH and Ha
HY brain homogenates
were digested with proteinase-K (PK) and analyzed by SDS-
PAGE and immunoblotting. Probing with anti-PrP antibody 3F4
revealed the expected glycoforms of PrP
C comprising of
unglycosylated and two glycosylated forms migrating between 27
and 37 kDa in the NH sample (Figure 1A, lane 1). Ha
HY showed
significantly more reactivity and additional bands migrating
between 19 and 37 kDa, typical of PrP
Sc (Figure 1A, lane 4).
Treatment with 50 and 100 mg/ml of PK digested all PrP
C in NH
(Figure 1A, lanes 2 and 3), whereas Ha
HY showed typical PK-
resistant PrP
Sc forms migrating between 19 and 30 kDa
(Figure 1A, lanes 5 and 6). Probing for Tf revealed relatively
higher expression in Ha
HY compared to NH (Figure 1A, lanes 1
and 4), and surprisingly, partially cleaved PK-resistant Tf forms
that migrated ,10 kDa faster in both NH and Ha
HY samples
(Figure 1A, lanes 2, 3, 5, 6). Similar resistance to PK was noted in
commercially available human Tf and normal and sCJD affected
human brain tissue (see below). Immunoblotting for ferritin
showed a significant increase in Ha
HY infected samples as
observed for Tf (data not shown). Quantitative estimation of
PrP, Tf, and ferritin after normalization with b-actin showed an
increase of 4.3, 2.8, and 2.9 fold respectively in Ha
HY compared to
matched NH samples (Figure 1B). (b-actin is cleaved by PK
(Figure 1A, lanes 2, 3, 5, 6). Estimation of ferrous (Fe (II)) and
ferric (Fe (III)) iron showed significantly more reactivity in Ha
HY
samples compared to matched NH samples as reported earlier for
diseased human and mouse brains (Figure 1C) [16]. Total iron was
increased by 4.9 fold in the Ha
HY sample relative to matched NH
samples (Figure 1D).
A similar evidence of iron imbalance is detected in
scrapie-infected mouse brains
A similar analysis of normal (NH) and scrapie infected end stage
mouse (MoSc) brain tissue showed increased accumulation of PrP
and up regulation of ferritin and Tf in MoSc samples compared to
matched controls (Figure 2A, lanes 1–3 and 4–7). Quantitative
estimation of PrP, ferritin, and Tf showed an increase of 4.9, 3.9,
and 1.4 fold respectively in MoSc compared to matched controls
(Figure 2B). In addition, MoSc samples revealed increased
reactivity for both Fe (II) and Fe (III) iron compared to matched
controls (Figure 2C) as noted for hamster samples above and
reported previously [18].
Autopsy and biopsy samples of sCJD brains show similar
evidence of iron imbalance
To evaluate if diseased human brains show a similar phenotype
of iron imbalance, brain homogenates from 20 cases of sCJD
(CJD+) and matched controls (CJD2) were fractionated by SDS-
PAGE and immunoblotted as above. Probing for PrP showed the
expected glycoforms migrating between 27 and 37 kDa in CJD2
samples (Figure 3, odd lanes). CJD+ samples showed relatively
Author Summary
Prion disorders are neurodegenerative conditions of
humans and animals that are invariably fatal. The main
agent responsible for neurotoxicity in all prion disorders is
PrP-scrapie (PrP
Sc), a b-sheet rich isoform of a normal cell-
surface glycoprotein, the prion protein (PrP
C). Deposits of
PrP
Sc in the brain parenchyma are believed to induce
neurotoxicity, though the underlying mechanisms are not
entirely clear. Emerging evidence from prion-infected cell
and mouse models implicates redox-iron in prion disease–
associated neurotoxicity. However, a systematic evaluation
of iron homeostasis in prion disease–affected brains and
the underlying mechanism of iron dyshomeostasis are
lacking. In this report, we demonstrate that prion disease–
affected human, mouse, and hamster brains exhibit a state
of iron deficiency in the presence of excess total brain iron,
resulting in a state of iron imbalance. The underlying cause
of this phenotype is likely sequestration of iron in cellular
ferritin that becomes detergent-insoluble, possibly due to
association with PrP
Sc. This results in a state of iron bio-
insufficiency, leading to increased iron uptake by the cells
and worsening of the state of iron imbalance. Since iron is
highly toxic if mismanaged, these results implicate iron
imbalance as a significant contributing factor in prion
disease–associated neurotoxicity.
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of PrP
Sc (Figure 3, even lanes). Re-probing for ferritin and glial
fibrillary acidic protein (GFAP), a marker for glial cells, showed an
inconsistent difference between CJD2 and CJD+ samples
(Figure 3, odd and even lanes). However, Tf and TfR revealed a
consistent increase in CJD+ samples compared to age-matched
controls (Figure 3, odd and even lanes).
Since autopsy samples represent end-stage disease and carry the
additional risk of artifacts due to post-mortem interval, a similar
evaluation was carried out on human biopsy samples. Due to
limited amount of biopsy tissue, PVDF membranes used for
diagnostic purposes were utilized. Membranes from two repre-
sentative CJD positive cases containing control (CJD2) and CJD
positive (CJD+) samples either left untreated or subjected to PK
treatment were reprobed for TfR, ferritin, Tf, and b-actin
(Figure 4, odd and even lanes, respectively). As noted for autopsy
samples, CJD+ biopsy samples demonstrated an increase in TfR
and Tf levels, and an insignificant difference in ferritin levels
compared to age-matched CJD2 controls after normalization
with b-actin (Figure 4, lanes 5–8, 13–16, 9–12). These results
provide confidence that the differences between CJD2 and CJD+
samples are not influenced by post-mortem interval. As observed
for diseased hamsters, Tf showed resistance to PK digestion in
CJD2 and CJD+ samples (Figure 4, lanes 14 and 16), a novel
finding that could prove useful in assessing the iron status of
healthy and diseased post-mortem brains. This observation was
therefore further validated by treating 10 and 5 ng of purified Tf
isolated from human plasma with 50 mg/ml of PK for 30 minutes
at 37uC in the presence of non-ionic detergents (Figure 5A, lanes
1–4). An aliquot (5 ml) of CJD2 brain homogenate was processed
in parallel (Figure 5A, lanes 5–8). Purified Tf migrated as a single
band (Figure 5A, lanes 1 and 3, black arrow) and was cleaved to
Figure 1. TME-infected hamster brains show alteration of brain iron homeostasis. (A) Normal (NH) and Ha
HY-infected hamster brains
harvested at the end stage of disease were homogenized, digested with 50 and 100 mg/ml of PK, and fractionated on SDS-PAGE, followed by
immunoblotting. PrP from NH is degraded completely by this treatment (lanes 1–3), whereas diseased brains show typical PK-resistant PrP bands
(lanes 4–6). Probing for Tf shows increased expression in the diseased sample (lanes 1 and 4). Surprisingly, Tf from both normal and diseased samples
is partially cleaved by this treatment and resists further degradation (lanes 2, 3, 5, 6). (B) Quantitative analysis of six different undigested samples after
normalization with b-actin shows a significant increase in PrP, Tf, and ferritin expression in the diseased sample compared to matched controls.
Values are mean6SEM. *p,0.0001, **p,0.001 relative to NH. n=6. (C) Equal protein from NH and Ha
HY brain homogenates was dot blotted on a
PVDF and reacted for Fe(II) and Fe(III) iron. Ha
HY sample shows significantly more reactivity for Fe(II) and Fe(III) iron compared to the NH sample. (D)
Estimation of total iron shows significantly more iron in the Ha
HY sample compared to matched NH samples. Values are mean6SEM. *p,0.005
relative to NH. n=4.
doi:10.1371/journal.ppat.1000336.g001
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and 4, open arrowhead). Brain Tf migrates as a doublet, probably
representing glycoforms of Tf (Figure 5A, lanes 5 and 7, black
arrow), and is cleaved to faster migrating forms by PK treatment
that co-migrate with similarly treated fragments of purified Tf
(Figure 5A, lanes 6 and 8, open arrowhead). A similar resistance to
PK has been reported for human brain ferritin [18].
To determine if the increase in Tf levels in CJD+ samples is
accompanied by an increase in its iron content, CJD2 and CJD+
samples were separated on a non-denaturing gel in duplicate.
Proteins were either reacted with Ferene-S, a dye that forms a blue
reaction product with iron (Figure 5B, lanes 1 and 2) [24], or
transblotted to a PVDF membrane and probed for ferritin and Tf
(Figure 5B, lanes 3 and 4), followed by silver staining of the
membrane (Figure 5B, lanes 5 and 6). An increase in the level of
ferritin and Tf expression and reactivity for iron was detected in
the CJD+ sample (Figure 5B, lanes 1–4, black arrowheads). The
slower migrating Tf reactive band probably represents a complex
or glycosylated form of Tf that does not react with ferene-S for
reasons that are unclear from our data (Figure 5B, lanes 2 and 4,
white asterisk). Separation of purified
59Fe labeled Tf on a similar
gel system reveals three labeled bands, though it is difficult to
Figure 2. Scrapie-infected mouse brains show alteration of iron homeostasis. (A) Normal (NH) and scrapie-infected (MoSc) mouse brains
collected at end stage of disease were homogenized and fractionated by SDS-PAGE, followed by immunoblotting. Probing with specific antibodies
shows increased expression of PrP, ferritin, and Tf in MoSc samples compared to matched controls (lanes 1–7). (B) Quantitative analysis after
normalization with b-actin shows a significant increase in PrP, ferritin, and Tf expression in diseased samples compared to matched controls. Values
are mean6SEM. *p,0.0001, **p,0.001 relative to NH samples. n=7. (C) Dot blot analysis as in Figure 1C shows a prominent reaction for Fe (II) and Fe
(III) iron in MoSc homogenates compared to matched controls.
doi:10.1371/journal.ppat.1000336.g002
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controls (CJD2) was homogenized and analyzed. Immunoblots of the first 11 cases are shown. Fractionation on SDS-PAGE followed by
immunoblotting shows an increase in PrP, Tf, and TfR expression in CJD+ samples (even lanes) compared to matched controls (odd lanes). Ferritin
and GFAP show an inconsistent difference between the two groups (lanes 1–22).
doi:10.1371/journal.ppat.1000336.g003
Figure 4. Biopsy samples of sCJD cases show similar evidence of brain iron imbalance. Representative PVDF membranes used previously
to diagnose CJD2 and CJD+ biopsy samples were re-probed sequentially for TfR, ferritin, Tf, and b-actin. (CJD2 and CJD+ samples matched for age
and disease duration are aligned for easier readout). Odd lanes show untreated controls, while even lanes show PK-treated samples. In CJD2
samples, PrP, TfR, and b-actin are completely degraded by PK treatment (lanes 2, 6, and 18), whereas CJD+ samples show typical PK-resistant forms of
PrP
Sc (lanes 4 and 8). Surprisingly, ferritin and Tf resist PK digestion in both CJD2 and CJD+ samples (lanes 9–16). CJD+ samples show an increase in
TfR and Tf levels relative to matched CJD2 samples (lanes 5–8 and 13–16, respectively). Ferritin shows little difference between the two samples
(lanes 9–12).
doi:10.1371/journal.ppat.1000336.g004
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correspond to the isoforms of
59Fe-Tf [19]. Silver staining of the
membrane shows two prominent unidentified bands in CJD2 and
CJD+ samples, and equal loading of protein in both samples
(Figure 5B, lanes 5 and 6, black asterisk).
Quantitative analysis of 20 CJD+ and an equal number of age-
matched CJD2 autopsy samples showed a significant increase in
PrP, Tf, and TfR levels in CJD+ samples by 1.5, 1.6, and 1.5 fold
respectively. The difference in ferritin levels between CJD2 and
CJD+ samples is statistically insignificant (Figure 5C). Variability
in the levels of different proteins within CJD2 and CJD+ samples
is shown in Figure 6A. The correlation between PrP and Tf was
0.05 in CJD2 samples, and significantly higher at 0.444 in CJD+
samples. A similar assessment of PrP and iron revealed a
correlation of 0.161 in CJD2 samples, and 0.274 in CJD+
samples. Correlation between iron and Tf was 0.042 in CJD2
samples as expected, and 0.319 in CJD+ samples (Figure 6A).
Although the correlation between PrP and ferritin was also higher
at 0.602 in CJD+ samples relative to 0.327 in CJD2 samples,
these observations could reflect the effect of astrogliosis with
disease progression. Correlative values for TfR were not
significantly different between the two groups. It is notable that
Figure 5. Purified and human brain Tf is PK-resistant. (A) Purified Tf (Sigma) and CJD2 brain homogenate were digested with 50 and 100 mg/
ml of PK and fractionated on SDS-PAGE, followed by immunoblotting. Purified and brain Tf are cleaved to faster migrating PK-resistant forms (lanes
1–8). (B) Samples from representative CJD2 and CJD+ cases were fractionated on non-denaturing gel and stained with the iron binding dye ferene-S
(lanes 1 and 2), or transblotted and probed for ferritin and Tf (lanes 3 and 4). CJD+ sample shows increased reaction for iron in ferritin and Tf (lanes 1–
4). Lack of iron reactivity by one of the oligomeric Tf forms may be due to inaccessibility of iron to ferene-S (lanes 2 and 4, white asterisk). Silver
staining of the same membrane confirms equal loading of protein in the two samples (lanes 5 and 6). (C) Quantification of autopsy samples analyzed
by immunoblotting shows increased expression of PrP, Tf, and TfR in CJD+ samples relative to matched controls. Values are mean6SEM. *p,0.0001,
**p,0.001 relative to CJD2 samples. n=40.
doi:10.1371/journal.ppat.1000336.g005
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suggesting similar iron levels at end stage disease despite obvious
differences in the background and disease course of each case
(Figure 6A) (see Materials and Methods). Comparison of total brain
iron in 55–66 year old CJD2 patients carrying no definitive
diagnosis with age-matched CJD+ cases shows a 1.4 fold increase of
total iron in the latter (Figure 6B). Other CJD2 samples, including
cases of Alzheimer’s disease, vascular disorders, dementia, and
inflammation showed high levels of iron, each varying with the
specific disease (Figure 6B). However, Tf and TfR levels did not
show a corresponding decrease perhaps due to precipitation of iron
in the extracellular space with little or no effect on cellular iron levels
(Figures 3, 5C, and 6A). Linear regression analysis of the above data
showed a positive correlation between PrP and Tf levels in CJD+
samples (R=0.444), not in CJD2 samples (R=0.05) (Figure 6C).
Immunostaining of brainsectionsrevealed increased reactivityforTf
in cerebellar Purkinje cell neurons of CJD+ cases (Figure 7),
indicating up-regulation of TfR expression in these cells. No visible
deposits of iron were detected in any brain region of CJD+ cases,
ruling out precipitation or co-aggregation of iron with PrP
Sc deposits
(data not shown).
Increased levels of Tf, an iron uptake protein, in the presence of
increased brain iron content observed above indicates imbalance of
iron homeostasis in prion disease affected brains. A positive
correlation between PrP and Tf levels further suggests that iron
deficiencymayoccurasaresultofPrP
Scaccumulation.Sinceasimilar
Figure 6. Correlation and linear reggression analysis of human autopsy samples. (A) Correlation between PrP and different proteins shows
a strong positive correlation between PrP and Tf, PrP and iron, and Tf and iron in CJD+ cases. CJD2 cases show no correlation between PrP and Tf
and between iron and Tf, and modest correlation between PrP and iron. (B) Quantification of total iron shows two distinct groups of CJD2 cases with
high and low iron content, the higher values arising most likely from specific disease conditions (see Materials and Methods). In contrast, CJD+ cases
show consistent iron levels in all 20 cases that are significantly higher than the apparently ‘‘disease-free’’ control group. Values are mean6SEM.
*p,0.001. n=20. (C) Linear regression analysis shows a positive correlation between PrP and Tf in CJD+ cases (R linear=0.444 for CJD+, and 0.05 for
CJD2). n=20.
doi:10.1371/journal.ppat.1000336.g006
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alterationofbrainironhomeostasisappearstooccurbeforeend-stage
disease. It is notable that Tf levels are unlikely to be affected by
secondary factors such as astrogliosis and neuronal loss, prominent
features of end-stage prion disease [11,12], and reflect neuronal iron
status.Inaddition,ourdataindicatethatTfisareliablemarkerofiron
status in post-mortem tissue since it resists digestion by proteinase K
and is likely to survive mild autolytic conditions.
Imbalance of iron homeostasis increases with disease
progression
To evaluate the relationship between PrP
Sc accumulation and
iron deficiency and to determine if imbalance of brain iron
homeostasis appears earlier during the incubation period, hamster
brain tissue harvested at 6, 9, and 12 weeks after inoculation with
263K strain of scrapie was analyzed. Immunoblot analysis showed
a significant increase in PrP levels with disease progression as
expected (Figure 8A, lanes 1–9). PK resistant PrP
Sc appeared 9
weeks after inoculation, and could be detected till 12 weeks, the
end stage of disease (Figure 8B, lanes 1–18). Tf and TfR levels
showed a significant increase at 9 weeks, and continued to increase
till end stage of disease at 12 weeks post-inoculation (Figure 8A,
lanes 4–9). Levels of GFAP, a marker of glial cells, showed a
significant increase at 9 weeks and little change there-after
(Figure 8A, lanes 4–9). Quantitative estimation of PrP, Tf, TfR,
and GFAP levels in 9 and 12 week samples relative to 6 week post-
inoculation samples revealed the following changes: PrP was
increased by 3.4 and 4.4 fold, Tf was increased by 3.8 and 4.0 fold,
TfR was increased by 5.2 and 5.7 fold, and GFAP was increased
by 7.0 and 7.8 fold (Figure 9). Since Tf is a reliable indicator of
brain iron status as demonstrated above, PrP and Tf levels at 6, 9,
and 12 weeks post-infection were plotted to quantify the strength
of association between the two proteins (Figure 10). Although
limited data points suggest caution in interpretation, our results
indicate highly significant and robust association indicating an
exponential increase in Tf levels with increase in PrP expression
(R
2=0.91) (Figure 10). These results suggest that the rate of
neuronal iron deficiency increases with PrP
Sc accumulation, with
substantially higher increase between 9 to 12 weeks relative to that
evidenced between 6 and 9 weeks. Since these hamsters are
relatively young and lack other associated diseases that could
contribute to these observations, our results suggest increasing iron
deficiency with increase in PrP
Sc accumulation.
Iron is sequestered in detergent-insoluble PrP
Sc–ferritin
complexes
It is plausible that a state of iron deficiency despite elevated iron
in diseased brains arises from sequestration of iron in biologically
Figure 7. Immunoreaction of normal and sCJD brain sections for Tf. Brain sections from CJD+ and matched controls were immunostained
with anti-Tf followed by DAB reaction. Purkinje cell neurons of CJD+ sections show strong reactivity for Tf. Low magnification images emphasize that
the difference in Tf reactivity is not limited to a few neurons (upper panels). Bar: 10 mm. n=3.
doi:10.1371/journal.ppat.1000336.g007
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Sc-ferritin aggregates as suggested in a previous
report [18]. To evaluate this possibility, N2a and prion infected
ScN2a cells were exposed to 0.1 mM ferrous ammonium citrate
(FAC) overnight to up-regulate ferritin expression. Treated cells
were radiolabeled with
59FeCl3-citrate complex for 4 hours and
chased in normal medium to accumulate
59Fe within ferritin. Cells
were lysed in native lysis buffer and analyzed as such, or
supplemented with 1% SDS for 10 minutes without boiling
(Figure 11A, lanes 1–4) or with boiling (Figure 11A, lanes 5 and 6).
Subsequently, the samples were separated by native gel electro-
phoresis followed by autoradiography. A prominent iron labeled
band was detected in both N2a and ScN2a lysates (Figure 11A,
lanes 1 and 3). (This band represents iron loaded ferritin as
determined by re-fractionation of eluted proteins from the labeled
band on SDS-PAGE followed by immunoblotting with anti-
ferritin antibody (Figure 11A, lanes 1–4, lower panel)). Exposure to
SDS dissociated a significant amount of iron from ferritin in N2a
lysates (Figure 11A, lanes 1 and 2), but had little effect on the iron
content of ferritin in ScN2a lysates (Figure 11A, lanes 3 and 4).
Boiling in the presence of SDS released all iron from ferritin in
both N2a and ScN2a lysates (Figure 11A, lanes 5 and 6). Silver
staining of lanes 2 and 4 showed insignificant difference in ferritin
protein levels in SDS treated N2a and ScN2a cells (Figure 11B),
indicating that the difference arose from the iron content of
ferritin. These results suggest that iron is sequestered in ‘SDS-
insoluble’ ferritin aggregates in ScN2a cells, most likely in
association with PrP
Sc. Similar results were obtained with scrapie
infected SMB cells, another prion infected cell line (data not
Figure 8. Scrapie-infected hamsters show increased iron deficiency with disease progression. (A) Immunoblot analysis of hamster brains
harvested 6, 9, and 12 weeks after inoculation with 263 K strain of scrapie shows an abrupt increase in PrP, Tf, TfR, and GFAP expression after 9 weeks,
and a further increase after 12 weeks (lanes 1–9). Reaction for b-actin shows protein loading for each sample. (B) The above homogenates were
treated with PK and immunoblotted. Reaction for PrP shows the appearance of PK-resistant PrP
Sc 9 and 12 weeks post-inoculation (lanes 1–18). b-
actin demonstrates protein loading, and is almost completely degraded by PK (lanes 1–18).
doi:10.1371/journal.ppat.1000336.g008
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N2a cells is significantly more compared to ScN2a cells
(Figure 11A, lanes 1 and 3), probably due to inaccessibility of
iron to aggregated ferritin in the latter.
Since PrP
Sc from CJD+ brain homogenates is several-fold more
resistant to PK digestion than PrP
Sc from ScN2a and SMB cells, a
similar evaluation was carried out on CJD2 and CJD+ brain
homogenates. Thus, commercially available purified ferritin,
CJD2 and CJD+ brain homogenates were suspended in native
lysis buffer or supplemented with 2% SDS and boiled for
10 minutes before separating on a non-denaturing gel. In-gel
staining of separated proteins with the iron binding dye Ferene-S
revealed a sharp blue band of iron in purified ferritin as expected,
which was lost on boiling due to release of iron from denatured
ferritin (Figure 12, lanes 1 and 2, respectively). A similar evaluation
of CJD2 and CJD+ samples showed more iron in CJD+ samples
relative to CJD2 controls under both conditions (Figure 12, lanes
3–6). A parallel set of samples was transferred to a PVDF
membrane under non-denaturing conditions and probed for
ferritin. Treatment of CJD2 samples with boiling SDS denatured
ferritin, some of which migrated with the dye front (Figure 12,
lanes 7 and 8). A similar treatment of CJD+ samples had minimal
effect on ferritin that migrated as oligomers without boiling, and as
a relatively compact band after boiling (Figure 12, lanes 9 and 10,
respectively). Re-probing for Tf revealed relatively higher levels in
the CJD+ sample, though the bands did not react with Ferene-S,
perhaps due to denaturation by SDS (Figure 12, lanes 11–14).
Silver staining of the same membrane revealed equal loading of
protein in all samples (Figure 12, lanes 15–18).
To evaluate the cellular site where PrP
Sc and ferritin associate,
ScN2a and SMB cells [22,23] analyzed in Figure 11 above were
immunostained for PrP and ferritin and examined (Figure 13). In
contrast to control ScN2a cells that displayed minimal reaction for
PrP and cytoplasmic staining for ferritin (Figure 13, panels 1–3),
FAC exposed ScN2a cells revealed prominent intracellular
reaction for PrP and ferritin, and significant co-localization of
the two proteins (Figure 13, panels 4–6). Scrapie infected SMB
cells showed significant intracellular reaction for PrP and minimal
Figure 9. Densitometric analysis of protein levels in Figure 8. Quantification of protein levels in Figure 8A after normalization with actin
shows a significant increase in PrP, TF, TfR, and GFAP levels at 9 and 12 weeks post-inoculation relative to the 6 weeks sample. Values are mean6SEM.
*p,0.001, **p,0.01 relative to NH samples. n=3.
doi:10.1371/journal.ppat.1000336.g009
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However, exposure to FAC revealed prominent intracellular
vesicles that reacted for both PrP and ferritin (Figure 13, panels
10–12).
Together, the above results indicate that PrP
Sc and ferritin form
detergent insoluble aggregates that sequester iron, creating a state
of relative iron deficiency in prion infected cells.
Discussion
In this report we demonstrate that prion infection induces a
state of iron imbalance in diseased human, hamster, and mouse
brains as revealed by a phenotype of iron deficiency in the
presence of increased total iron. The phenotype of iron deficiency
appears early in the disease process, probably with the initiation of
PrP
Sc formation, and is not an outcome of end-stage disease. An
important underlying cause of iron imbalance is sequestration of
cellular iron in detergent insoluble PrP
Sc-ferritin complexes, thus
rendering it bio-unavailable and creating a phenotype of apparent
iron deficiency. Consequent up-regulation of iron uptake proteins
Tf and TfR result in increased cellular iron uptake, creating a state
of cellular iron imbalance. Since iron is potentially toxic due to its
redox-active nature, these observations have significant implica-
tions for prion disease associated neurotoxicity.
In evaluating iron homeostasis in healthy and diseased brains,
we have focused primarily on total brain iron and levels of Tf and
TfR. Although these parameters do not represent changes in iron
levels in individual cell types that comprise the complex milieu of
the brain, these are reliable markers of neuronal iron levels, the
principal cell type affected in prion disorders [14]. The
mechanisms underlying brain iron homeostasis are complex, and
details of iron import and export from various cells within the
brain are still emerging. Normally, iron enters the brain through
Figure 10. Correlation analysis of PrP and Tf. Association
between PrP and Tf levels during disease progression was estimated
by curve-fitting procedures. Exponential curve provided the best fit to
the data indicated by R
2=0.9114.
doi:10.1371/journal.ppat.1000336.g010
Figure 11. Iron is sequestered within ferritin in ScN2a cells and sCJD brains. (A) N2a and ScN2a cells cultured in the presence of 0.1 mM
FAC were radiolabeled with
59FeCl3-citrate complex and lysed in native lysis buffer. Equal aliquots of the sample were either left aside, supplemented
with 2% SDS, or supplemented with 2% SDS and boiled. All samples were resolved on a native gel followed by autoradiography. N2a lysates in native
lysis buffer lacking SDS show significantly more incorporation of
59Fe into ferritin than ScN2a lysates (lanes 1 and 3). Following incubation with 2%
SDS, a significant proportion of
59Fe dissociates from ferritin in N2a lysates, whereas the ScN2a sample shows little change (lanes 2 and 4). Boiling in
SDS releases all
59Fe from ferritin in both N2a and ScN2a samples (lanes 5 and 6). Lower panel: Iron labeled band from N2a and ScN2a samples was
eluted with boiling SDS and re-fractionated on SDS-PAGE, followed by immunoblotting with anti-ferritin antibody. The eluted proteins react strongly
for ferritin, as described in a previous report [19]. (B) Silver staining of the same samples fractionated in (A) shows similar levels of ferritin following
incubation with SDS, indicating only a change in iron content by this treatment.
doi:10.1371/journal.ppat.1000336.g011
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delivered to the brain interstitium using mechanisms that are still
debated. Once in the brain, iron is bound by citrate, ascorbate,
and Tf present in the interstitial fluid. Citrate and ascorbate are
mainly released by astrocytes, and brain Tf is derived from cells of
the choroid plexus and oligodendrocytes and is saturated with iron
under normal conditions. Neurons take up most of their iron from
Tf through TfR mediated uptake. Under conditions of iron
deficiency, neurons up-regulate TfR levels to internalize increased
amounts of iron saturated Tf to make up for the deficiency. The
opposite scenario holds true when iron is in excess. In contrast to
other cell types such as astrocytes, oligodendrocytes, and
microglia, neurons in most brain regions lack the iron storage
protein ferritin, necessitating efflux of excess iron through the iron
export protein ferroportin. Astrocytes, microglia, and oligoden-
drocytes lack TfR, and take up most of their iron through other
mechanisms [2,14–16]. Thus, TfR levels in the brain reflect the
iron status of neurons, the most vulnerable cell population in prion
disorders. However, experimental manipulation of brain tissue
often results in the degradation of TfR, providing inconsistent
results from post-mortem brains and animal brains unless the
tissue is handled with extreme care. Tf, on the other hand, is as
resilient to degradation as PrP
Sc, and reflects TfR levels as
demonstrated by our immunohistochemistry and immunoblot
data from animal and human brains. It is for these reasons that we
have focused on Tf and iron levels, and where possible, TfR levels
to evaluate brain iron status in prion disease affected brains.
Using the above criteria, our data demonstrate the presence of
iron imbalance in prion disease affected brains from three different
species, human, hamster, and mice. Although alteration of brain
iron has been described in other neurodegenerative diseases such
as AD and PD, it is notable that the changes in iron homeostasis in
prion disease affected brains are distinct [1–4]. A prominent
difference is the apparent phenotype of iron deficiency in prion
disease affected brains despite increased brain iron content. A
direct correlation between PrP and Tf levels in both sCJD and
infected hamster samples suggests that iron deficiency arises as a
direct consequence of PrP
Sc accumulation, perhaps by forming
PrP
Sc-ferritin complexes as noted in scrapie infected cells and
reported earlier [18,25]. An increase in Tf and TfR levels is also
noted in human biopsy samples, indicating that brain iron levels
decrease much before the onset of end-stage pathology. The
presentation of AD and PD brains, however, is strikingly different.
In the pool of CJD2 cases examined in this report, several samples
contained high levels of iron, including cases of AD, PD, dementia
of unknown origin, and vascular disorders. As opposed to prion
disease affected brains, these cases demonstrated a consistent
down-regulation of Tf and TfR as expected, suggesting that the
increased iron content was probably derived from insoluble
deposits in the extra-cellular space. Brains from sCJD cases, on
the other hand, show a modest and a surprisingly similar increase
in iron content across twenty samples and a significant increase in
Tf levels, suggesting a common pathway of iron accumulation and
sequestration by scrapie infection.
The data on scrapie infected hamsters support the above
conclusions. In these animals, iron deficiency appears almost at the
same time as PK-resistant PrP
Sc, and worsens with disease
progression as indicated by increasing levels of Tf and TfR till
end stage disease. Since this analysis was performed on
experimental brains that were snap frozen after harvesting, the
Figure 12. Ferritin from sCJD brain tissue is detergent-insoluble and retains iron. Commercially available purified ferritin and
homogenates from CJD2 and CJD+ brains were supplemented with 2% SDS and either left at room temperature, or boiled before resolving on a
non-denaturing gel. The iron contained in purified ferritin reacts strongly with Ferene-S, but is lost after boiling (lanes 1 and 2). Relative to CDJ2
samples, CJD+ samples show more reactivity with ferene-S even after boiling with SDS (lanes 3–6). Immunoblotting with ferritin shows a strong
reaction in both CJD2 and CJD+ samples. However, boiling in SDS denatures a significant amount of ferritin in the CJD2 samples, while it has no
effect on the CJD+ sample (lanes 7–10, black arrowheads). Reprobing for Tf shows relatively stronger reaction in the CJD+ sample, and partial
denaturation by SDS in both samples (lanes 11–14, open arrowheads). Silver staining of the same membranes confirms equal loading of protein in all
samples (lanes 15–18).
doi:10.1371/journal.ppat.1000336.g012
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PLoS Pathogens | www.plospathogens.org 12 March 2009 | Volume 5 | Issue 3 | e1000336Figure 13. Scrapie-infected cells show co-localization of PrP and ferritin. ScN2a and SMB cells cultured in the absence or presence of
0.1 mM FAC were immunostained with 8H4-anti-mouse-FITC followed by anti-ferritin–anti-rabbit-TRITC. Untreated ScN2a cells show minimal PrP
reactivity and reaction for ferritin in the cytosol (panels 1–3). Following exposure to FAC, both PrP and ferritin form intracellular aggregates that co-
localize for the most part (panels 4–6, arrowheads). Untreated SMB cells show intracellular aggregates of PrP and reaction for ferritin in the cytosol
(panels 7–9). However, exposure to FAC increases the reactivity for PrP and ferritin significantly, and, notably, PrP and ferritin form intracellular
aggregates that co-localize in vesicular structures (panels 10–12, arrowheads).
doi:10.1371/journal.ppat.1000336.g013
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measure of neuronal iron deficiency, further supported by an
increase in Tf that is likely to reflect TfR levels as observed in the
Purkinje cell neurons of CJD+ samples. Since most neurons lack
ferritin iron stores [14], such a situation is likely to result in
compromised neuronal health and toxicity. It is unlikely that
advanced age contributes to the iron imbalance observed in prion
disease affected brains since the hamster brains used for this
evaluation range in age from ten to sixteen weeks, a relatively
young age considering the life-span of hamsters. It is interesting to
note that the extent of iron accumulation varies with the strain of
prions used for infecting the experimental animal. Hamsters
infected with TME accumulate much higher levels of total and
redox-active iron than those infected with the 263K strain of
scrapie (unpublished observations). However, the increase in Tf
levels is similar in both cases, suggesting that iron in some cases
precipitates in the extra-cellular space and does not alter the
intracellular iron status.
The most likely cause of iron deficiency in prion disease affected
brains is the sequestration of iron in PrP
Sc-ferritin aggregates as
noted in scrapie infected cells and sCJD brain tissue. In a previous
report we demonstrated that PrP
Sc from sCJD and scrapie infected
mouse tissue forms a PK-resistant, detergent insoluble complex
with ferritin [18,25]. Here we show that ferritin from sCJD
affected brains sequesters iron, and is not denatured by boiling in
2% SDS for ten minutes. Ferritin from normal human brains is
denatured by this treatment and releases bound iron. A similar
observation is noted in scrapie infected cell lines, though cellular
ferritin is less resistant to SDS. These observations suggest that
ferritin co-aggregates with PrP
Sc to form a detergent insoluble
complex and sequesters the associated iron, creating a state of iron
deficiency. Such an occurrence would explain the development of
iron deficiency with the appearance of PrP
Sc, increased levels of
total iron in diseased brains, a direct correlation between PrP and
Tf levels, and an overall state of iron imbalance in diseased brains.
Although ferritin is mainly cytosolic, it is known to undergo
degradation within the lysosomes, the cellular compartment where
PrP
Sc and ferritin are observed in scrapie infected cells, and are
hence likely to form the complex [18].
To summarize, this report demonstrates that brain iron
imbalance is a common feature of prion disease affected brains,
and is likely to contribute to prion disease associated neurotoxicity
due to the redox-active nature of iron. The underlying cause of
iron imbalance is the formation of PrP
Sc-ferritin complexes, a
pathogenic process that may lend itself to therapeutic manipula-
tion, thus providing a means to reduce disease associated
neurotoxicity.
Materials and Methods
Cell lines, chemicals, and antibodies
Mouse neuroblastoma cells (N2a) and ScN2a cells were
obtained from Dr. Byron Caughey (Rocky Mountain laborato-
ries), and scrapie infected SMB cells (mouse brain cells of
mesenchymal origin were obtained from the TSE Resource
Center, Institute of Animal Health (Edinburgh, Scotland). PrP-
specific monoclonal antibodies 3F4 and 8H4 were obtained from
Signet (Dedham, MA, USA) and Drs. Man-Sun Sy and Pierluigi
Gambetti (National Prion Surveillance Center, Case Western
Reserve University). Anti-ferritin antibody was from Sigma-
Aldrich (St. Louis, MO), anti-Tf from GeneTex (San Antonio,
TX) and anti-TfR antibody from Zymed Laboratories Inc
(Carlsbad, CA). Horseradish peroxidase (HRP)-labeled second-
ary antibodies were from GE Healthcare (Little Chalfont,
Buckinghamshire, United Kingdom). All other chemicals were
purchased from Sigma.
Brain tissue samples
Frozen human brain tissue from the frontal cortex of CJD+ and
matched controls (CJD2) was obtained from the National Prion
Surveillance Center, Case Western Reserve University. Additional
samples of control tissue (CJD2) were obtained from the Harvard
Tissue Bank. Collectively, the samples ranged in age from 37–80
years, and the disease duration ranged from 1–24 months in
CJD2, and 2 to 4 months in CJD+ cases. CJD2 cases carried the
diagnosis of extensive infarcts, possible granulomatous angiitis,
cerebral vascular disease, and necrotizing lymphoplasmacytic
meningoencephalitis (1 case each), Alzheimer’s disease (5 cases),
and no definitive diagnosis (11 cases). CJD+ cases were classified as
MM1 (11 cases), VV1 (2 cases), VV2 (4 cases), and MV2 (3 cases).
Male and female representation was almost equal among the
CJD2 and CJD+ groups. Given the heterogeneity in the two
groups, samples were matched only for age when loading on SDS-
PAGE. For SDS-PAGE, 10% homogenate was prepared in lysis
buffer (10 mM Tris, pH 7.5, containing 150 mM NaCl, 0.5%
sodium deoxycholate, 0.5% nonident P-40 containing PMSF and
Protease inhibitor cocktail). For determination of iron, the sample
was prepared in PBS and analyzed using the Teco diagnostic kit as
described below. Brain biopsy samples were obtained from the
Prion Disease Surveillance Center at Case Western Reserve
University, and represent individuals ranging in from 46 and 80
years. CJD2 cases presented with positive neurological symptoms
for 1–12 months, and CJD+ cases for 2–4 months. Due to the
limited amount of tissue available from biopsies, PVDF mem-
branes used for diagnostic purposes were re-probed to evaluate the
expression of major iron regulatory proteins ferritin, Tf and TfR.
Control and TSE infected end stage hamster brain tissue was
obtained from Jason Bartz (Department of Medical Microbiology
and Immunology, Creighton University, Omaha, Nebraska) [21]
was analyzed as abovefor protein analysis, and homogenized inPBS
for estimating total, Fe(II), and (Fe(III) iron [26]. To evaluate the
point of initiation of iron dyshomeostasis during disease progression,
hamster brain tissue collected at 6, 9, and 12 weeks after inoculation
with 263K strain of scrapie was obtained from Qingzhong Kong
(CaseWesternReserveUniversity).Halfbrainfromeachsamplewas
homogenized in lysis buffer analyzed for PK resistant PrPSc as well
as expression of other proteins. Control and scrapie infected end
stage mouse braintissue(strains 137A and 22L) was generated inour
facility and obtained from Jason Bartz and analyzed as above.
Proteinase-K digestion, SDS-PAGE, and Western blotting
Normal (NH) and diseased brains homogenized in lysis buffer
(10 mM Tris, pH 7.5, containing 150 mM NaCl, 0.5% sodium
deoxycholate, 0.5% nonident P-40) were incubated with 50 and
100 mg/ml of PK at 37uC for h. Digestion was stopped by addition
of 1 mM PMSF and protease inhibitor cocktail. Digested and
undigested samples were processed for SDS-PAGE and Western
blotting as described previously [27,28]. Membranes containing
transferred proteins were probed with anti-PrP antibodies 3F4
(1:5000) or 8H4 (1:3000), anti-ferritin (1:1000), anti-Tf (1:6000),
anti-TfR (1:3000), anti-GFAP (1:2000), and anti-b-actin (1:7500)
followed by appropriate secondary antibody conjugated with
horseradish peroxidase (1:6000). Immunoreactive bands were
visualized by ECL detection system (Amersham Biosciences Inc.).
Determination of iron in brain homogenates
A colorimetric method (Teco Diagnostics, Anaheim, CA) was
used to estimate total iron in brain homogenates according to the
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PBS was dissolved in 1 ml of acetate buffer containing 220 mM
Hydroxylamine hydrochloride, pH 4.5 and 50 ml of 16.6 mM
Ferrozine was added to develop the color. The change in color was
recorded at 560 nm after 10 minutes of incubation at 37uC using
500 mg/dl FeCl2 solution as standard. Negative controls were
recorded without the addition of ferrozine and background was
subtracted from test samples.
Radiolabeling with
59FeCl3 and native gradient gel
electrophoresis
Mouse neuroblastoma cells (N2a) and scrapie infected ScN2a
and SMB cells were cultured in the absence or presence of
0.1 mM ferrous ammonium citrate and labeled with
59FeCl3-
citrate complex (1 mM sodium citrate and 2 mCi of
59FeCl3 in
serum free Opti-MEM) overnight at 37uCi n5 %C O 2 in a
humidified atmosphere. Washed cells were lysed in native lysis
buffer (0.14 M NaCl, 0.1 M HEPES, pH 7.4, 1.5% Triton X-
100 and 1 mM PMSF), and half of each sample was
supplemented with 10 ml of 10% SDS for 10 minutes at room
temperature. Both parts were mixed with glycerol, traces of
bromophenol blue, and resolved on 3–9% native gradient gel as
described by Petrak and Vyoral [29,30] with modifications [19].
Gels were vacuum dried and exposed to X-ray film to visualize
labeled bands. A duplicate set of samples was analyzed on native
gel, and the radioactive band was eluted with boiling SDS and
re-fractionated on a SDS-PAGE gel followed by immunoblotting
with anti-ferritin antibody.
Detection of iron on native gel with Ferene S
Brain homogenates prepared in 5 mM HEPES pH 7.4, 0.25 M
sucrose and protease inhibitors were resolved on native gradient
gels (3–9%) without Triton X-100 and stained for iron with freshly
prepared Ferene-S (0.75 mM 3-[2-pyridyl]-5, 6-bis (2-[-furyl
sulfonic acid]-2, 4-triazine, 2% (v/v) acetic acid, 0.1% thioglycolic
acid) [24] for 30 min at 37uC. A dark blue stain indicates the
presence of iron or iron-bound protein. The identity of iron
stained bands was confirmed by immunoblotting with specific
antibodies.
Detection of redox-iron
Prussian blue reaction was used to detect redox-active ferrous
and ferric iron in brain homogenates as described in [26].
Immunostaining of brain sections
Paraffin embedded cerebellar sections of CJD+ cases and age
matched controls were deparafinized with methanol followed by
exposure to 8% H2O2 and water. Cleared sections were incubated
with 10% NGS followed by anti-Tf antibody (1:20 in 1% NGS)
overnight at 4uC. After washing with TBS the sections were
incubated with peroxidase-conjugated secondary antibody for
60 min and developed with DAB.
Immunostaining and fluorescence microscopy
N2a and SMB cells exposed to FAC were processed for
immunostaining as described in a previous report [18].
Analysis of iron–PrP
Sc–ferritin aggregates from sCJD
brain homogenates
Human brain tissue from CJD+ and matched controls (CJD2)
homogenizedinPBSwasusedfortheanalyses.Brainhomogenatewas
mixed with native lysis buffer (0.14 M NaCl, 0.1 M Hepes, 1.5%
TritonX-100,1 mMPMSF,PH 7.4),orsupplementedwith2%SDS.
Samples were either incubated at 37uCo rb o i l e df o r1 0m i na n d
resolved by 3–9% native gradient gel. Iron levels were detected by
FereneSstainingasdescribedabove.Toconfirmtheidentityofferritin
and Tf, proteins were immunoblotted under native conditions as
describedpreviously[19]andmembraneswereprobedforferritinand
Tf. Equal loading was confirmed by silver staining of membranes.
Statistical analysis
Data are presented as the mean SEM values. Statistical
evaluation of the data was performed by using Students t-test
(unpaired). Regression analysis was performed by standard
statistical methods and the Stata (2005) statistical package.
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